ROYCE & ASSOCIATES LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$9,0000.0%12,892
-28.7%
0.00%
Q3 2020$9,000
-30.8%
18,0790.0%0.00%
Q2 2020$13,000
-23.5%
18,0790.0%0.00%
Q1 2020$17,000
-67.3%
18,079
-29.0%
0.00%
Q4 2019$52,000
-28.8%
25,4770.0%0.00%
-100.0%
Q3 2019$73,000
-60.5%
25,477
+5.8%
0.00%
-50.0%
Q2 2019$185,000
+478.1%
24,075
+889.5%
0.00%
Q1 2019$32,000
+23.1%
2,433
+48.1%
0.00%
Q4 2018$26,000
-18.8%
1,643
+1.8%
0.00%
Q3 2018$32,000
+100.0%
1,614
+183.2%
0.00%
Q2 2018$16,000
+60.0%
570
+41.8%
0.00%
Q1 2018$10,0004020.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders